期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清半胱氨酸蛋白酶抑制剂C在冠心病患者早期肾功损伤中的临床意义

下载PDF
导出
作者 富炳罡
机构地区 大连市旅顺口区人民医院检验科
出处 《中国实验诊断学》 北大核心 2010年第2期266-268,共3页 Chinese Journal of Laboratory Diagnosis
关键词 血清半胱氨酸蛋白酶抑制剂C 冠心病患者 临床意义 冠状动脉粥样硬化性心脏病 损伤 肾功 早期 危险因素
分类号 R541.4 [医药卫生—心血管疾病] R446.6 [医药卫生—诊断学]
  • 相关文献

参考文献9

  • 1黄萍.评估肾脏功能的一种更敏感指标—胱蛋白C[J].国外医学（泌尿系统分册）,2001,21(5):228-229. 被引量：13
  • 2吴光哲,张必利,郑兴,秦永文.慢性肾脏病与冠心病相关性的临床研究[J].心血管康复医学杂志,2006,15(5):447-450. 被引量：17
  • 3Anavekar N S, Mc Murray JJ, Velazquez E J, et al. Relation between renal dysfunction and caediovascular outcomes after myocardial infarction[J]. N Engl J Med,2004,351 : 1285.
  • 4JH IX,M G Shlipak, G M Chertow, et al. Association of Cystatin C with Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Date from the Heart and Soul Study [J]. Circulation,2007,115(2) : 173.
  • 5刘嘉芳,杨清萍,徐金英,崔蒙,江力勤,钱钢,陈浩,汪世军,唐关敏,王蕾敏,刘建迪.Cyst-c浓度对检出高血压、冠心病患者早期肾损害的价值[J].心脑血管病防治,2004,4(6):11-13. 被引量：8
  • 6Pinkan T, Hilgers K F, Veelken R, et al. How does minommenal dysfunction influence eardiovascular risk and the management of diocascular disease[J].J Am Soc Nephrol,2004,5(3):517.
  • 7Shlipak M G, Fride L F, Crump C, et al. Elevation of inflammatory and prociagulant biomarkers in elderly persons with renal insufficiency[J]. Circulation, 2003,107 : 87.
  • 8杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量：41
  • 9Jernberg T, Lindahl B, James S, et al, Cytatin: a novel predictor of outcomes in suspected or condirmed non-ST-elevation acute coronary syndrome [J]. Circulation, 2004,110 : 2342.

二级参考文献53

  • 1杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量：41
  • 2[1]Coll E, Botey A, Alvarez L, et al. Serum cystatin C as new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis, 2000, 36(1) :29 - 34.
  • 3[3]Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis, 2001,37(1):79-83.
  • 4[4]Newman DJ, Thankkar H, Robert G, etal. Serum cystatin C measured by automated immunoassay. A more sensitive marker of changes in GFR than serum creatinine. Kidney Int, 1995, 47:312-318.
  • 5Foley RN, Parfrey PS, Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32(5 Suppl 3):S112-S119.
  • 6Witko-Sarsat V, Friedlander M, Capeillere-Blandin C,et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia.Kidney Int, 1996,49:1304-1313.
  • 7Witko-Sarsat V, Friedlander M, Nguyen Khoa T,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161:2524-2532.
  • 8Stein G, Busch M, Muller A, et al.Are advanced glycation end products cardiovascular risk factors in patients with CRF?Am J Kidney Dis,2003,41(3 Suppl 1):S52-S56.
  • 9Craven TE, Ryu JE, Espeland MA,et al.Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.Circulation,1990,82:1230-1242.
  • 10Stenvinkel P, Heimburger O, Paultre F,et al.Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.Kidney Int,1999,55:1899-1911.

共引文献73

中国实验诊断学
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部